Ngā hua rapu - Arissa Young

  • E whakaatu ana i te 1 - 6 hua o te 6
Whakamahine hua
  1. 1
    Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma

    Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma mā Arissa Young, Henry T. Quach, Haocan Song, Elizabeth J. Davis, Javid J. Moslehi, Fei Ye, Grant R. Williams, Douglas B. Johnson

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Hematologic Complications of Immune Checkpoint Inhibitors

    Hematologic Complications of Immune Checkpoint Inhibitors mā Elizabeth J. Davis, Joe‐Elie Salem, Arissa Young, Jennifer R. Green, P. Brent Ferrell, Kristin Kathleen Ancell, Bénédicte Lebrun‐Vignes, Javid J. Moslehi, Douglas B. Johnson

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand

    Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 re... mā James R. Patrinely, Arissa Young, Henry T. Quach, Grant R. Williams, Fei Ye, Run Fan, Leora Horn, Kathryn E. Beckermann, Erin A. Gillaspie, Jeffrey A. Sosman, Debra L. Friedman, Javid J. Moslehi, Douglas B. Johnson

    I whakaputaina 2020
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus

    Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus mā Kelsey Voss, Allison E. Sewell, Evan Krystofiak, Katherine N. Gibson‐Corley, Arissa Young, Jacob H. Basham, Ayaka Sugiura, Emily N. Arner, William N. Beavers, Dillon E. Kunkle, Megan E. Dickson, Gabriel A. Needle, Eric P. Skaar, W. Kimryn Rathmell, Michelle J. Ormseth, Amy S. Major, Jeffrey C. Rathmell

    I whakaputaina 2023
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

    Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆ mā C. Owen, Alexander N. Shoushtari, D Chauhan, David Palmieri, Belinda Lee, Maartje W. Rohaan, Joanna Mangana, Victoria Atkinson, Farzana Y. Zaman, Arissa Young, Christoph Höeller, Peter Hersey, R. Dummer, Muhammad A. Khattak, Michael Millward, Sapna P. Patel, Andrew Haydon, Douglas B. Johnson, Serigne Lo, Christian U. Blank, Shahneen Sandhu, Matteo S. Carlino, James Larkin, Alexander M. Menzies, Georgina V. Long

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function

    MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function mā Ayaka Sugiura, Gabriela Andrejeva, Kelsey Voss, Darren R. Heintzman, Xincheng Xu, Matthew Z. Madden, Xiang Ye, Katherine L. Beier, Nowrin U. Chowdhury, Melissa M. Wolf, Arissa Young, Dalton Greenwood, Allison E. Sewell, Shailesh K. Shahi, Samantha N. Freedman, Alanna M. Cameron, Patrik Foerch, Tim Bourne, Juan Carlos García‐Cañaveras, John Karijolich, Dawn C. Newcomb, Ashutosh K. Mangalam, Joshua D. Rabinowitz, Jeffrey C. Rathmell

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: